UniProtKB/SwissProt variant VAR

Variant information

Variant position:

161

The position of the amino-acid change on the UniProtKB canonical protein sequence.

Type of variant:

LP/P [Disclaimer]

The variants are classified into three categories: LP/P, LB/B and US.

LP/P: likely pathogenic or pathogenic.
LB/B: likely benign or benign.
US: uncertain significance

Residue change:

From Arginine (R) to Glutamine (Q) at position 161 (R161Q, p.Arg161Gln).

Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.

Physico-chemical properties:

Change from large size and basic (R) to medium size and polar (Q)

The physico-chemical property of the reference and variant residues and the change implicated.

BLOSUM score:

1

The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:

Lowest score: -4 (low probability of substitution).
Highest score: 11 (high probability of substitution).

More information can be found on the following page

Variant description:

In SSMED; no expression of the protein is observed; complete loss of function in DNA double-strand break repair.

Any additional useful information about the variant.

Other resources:

Links to websites of interest for the variant.

Variant rs797045017 [ dbSNP | Ensembl ]

Sequence information

Variant position:

161

The position of the amino-acid change on the UniProtKB canonical protein sequence.

Protein sequence length:

336

The length of the canonical sequence.

Location on the sequence:

NEHLQKENERLLRDWNDVQG R FEKCVSAKEALETDLYKRFI

The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.

Residue conservation:

The multiple alignment of the region surrounding the variant against various orthologous sequences.

Human                         NEHLQKENERLLRDWNDVQGRFEKCVSAKEALETDLYKRFI

Mouse                         NEHLQKENERLLRDWNDVQGRFEKCVSAKEALEADLYQRFI

Slime mold                    NQTLTLQTQSLQSQFNQSLEQNKLFQLEKDRIESNLIEKFI

Sequence annotation in neighborhood:

The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:

Type: the type of sequence feature.
Positions: endpoints of the sequence feature.
Description: contains additional information about the feature.

Type	Positions	Description
Chain	1 – 336	DNA repair protein XRCC4
Region	1 – 213	Interaction with IFFO1
Coiled coil	131 – 165
Mutagenesis	170 – 170	E -> A. Abolished DNA-binding.

Literature citations

Mutations in XRCC4 cause primary microcephaly, short stature and increased genomic instability.
Rosin N.; Elcioglu N.H.; Beleggia F.; Isgueven P.; Altmueller J.; Thiele H.; Steindl K.; Joset P.; Rauch A.; Nuernberg P.; Wollnik B.; Yigit G.;
Hum. Mol. Genet. 24:3708-3717(2015)
Cited for: VARIANTS SSMED GLN-161 AND 275-ARG--ILE-336 DEL; CHARACTERIZATION OF VARIANT SSMED GLN-161;

UniProtKB/Swiss-Prot variant pages

UniProtKB/Swiss-Prot Q13426: Variant p.Arg161Gln